Skip to main content

RFLP Markers of Familial Coronary Heart Disease

  • Chapter
Book cover DNA Polymorphisms as Disease Markers

Part of the book series: NATO ASI Series ((NSSA,volume 214))

Abstract

In two population samples of men aged 30–59 years from the North of Edinburgh, a higher frequency of CHD in those with a family history of the disease in close relatives before age 60 was strongly associated with the allele status of four RFLP in the apo AI/CIII/AIV gene region. In a simultaneous multiple logistic regression analysis of CHD on a number of covariates, a family history emerged with significant odds ratio of 2.553 (p = 0.034) in subjects with minor RFLP alleles in one of the samples and with odds ratio of 3.611 (p = 0.016) in those homozygous for major alleles in the other. The apo AI/CIII/AIV related effect of family history on evidence of CHD was independent of all other variables tested, which included age, cigarette smoking, hypertension, hyperlipldaemia, socio-economic group and obesity. There was no evidence of a familial environment effect or of genotype environment interaction. The results of these studies suggest that genetic liability to CHD is influenced significantly by a locus or loci in the apo AI/CIII/AIV gene region. Since the association of this region with familial CHD involves different alleles or haplotypes in different sections of the population (different linkage phase) no single allele or haplotype identifies an individual with increased liability to CHD on account of this association. This may explain the apparently conflictng results obtained in case control studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Neufeld HN, Goldbourt U. Coronary Heart Disease: Genetic Aspects. Circulation 1983; 67: 943–54.

    Article  PubMed  CAS  Google Scholar 

  2. Goldbourt U, Neufeld HN. Genetic Aspects of Arteriosclerosis. Arteriosclerosis 1986; 6: 357–77.

    Article  PubMed  CAS  Google Scholar 

  3. Hopkins PN, Williams RR. Human Genetics and Coronary Heart Disease: A Public Health Perspective. Annu Rev Nutr 1989; 9: 303–45.

    Article  PubMed  CAS  Google Scholar 

  4. Karathanasis SK, Norum RA, Zannis VI, Breslow JL. An Inherited Polymorphism in the Human ApolipoproteinAI Gene Locus related to the Development of Atherosclerosis. Nature 1983; 301: 718–20.

    Article  PubMed  CAS  Google Scholar 

  5. Rees A, Shoulders CC, Stokes J, Galton DJ, Baralle FE. DNA Polymorphism adjacent to Human Apo-Protein A-I Gene. Relation to Hypertriglyceridaemia. Lancet 1983; i: 444–6.

    Article  Google Scholar 

  6. Ferns GAA, Galton DJ. Haplotypes of Human Apolipoprotein AI-CIII-AIV Gene Cluster in CoronaryAtherosclerosis. Hum Genet 1986: 73: 245–9.

    Article  PubMed  CAS  Google Scholar 

  7. Breslow JL. Apolipoprotein Genetic Variation and Human Disease. Physiol Rev 1988; 68: 85–132.

    PubMed  CAS  Google Scholar 

  8. Fisher EA, Coates PM and Cortner JA. Gene Polymorphisms and Variability of Human Apolipoproteins. Annu Rev Nutr 1989; 9: 139–60.

    Article  PubMed  CAS  Google Scholar 

  9. Sing FC, Moll PP. Genetics of variability of CHD risk. Int J Epidemiol 1989; 18: 5183–95

    Google Scholar 

  10. Price WH, Morris SW, Kitchin AH, Wenham PR, Burgon PRS and Donald PM. DNA restriction fragment length polymorphisms as markers of familial coronary heart disease. Lancet 1989; i: 1407–1410

    Article  Google Scholar 

  11. Price WH, Morris SW. Kitchin AH, Wenham PR, Lowther JL, M’Kenzie PRS and Donald PM.Further evidence implicating the apo AI/CIII/ AN gene region in genetic liability to CHD. In preparation.

    Google Scholar 

  12. Kunkel LM, Smith KD, Boyer SH, et al. Analysis of Y Chromosome Specific Reiterated DNA inChromosome Variants. Proc Natl Acad Sci USA 1977; 74: 1245–49.

    Article  PubMed  CAS  Google Scholar 

  13. Lee J. Covariance adjustment of rates based on the multiple logistic regression model. J Chron Dis1981; 34: 415–426

    Article  PubMed  CAS  Google Scholar 

  14. Falconer DS. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Gen 1965; 29 51–62

    Article  Google Scholar 

  15. Shaper AG, Pocock SJ. Walker M, Phillips AN, Whitehead TP, Macfarlane PW. Risk factors for ischaemic heart disease: the prospective phase of the British regional heart study. J Epid CommHealth 1985; 39: 197–209

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Price, W.H., Kitchin, A.H. (1991). RFLP Markers of Familial Coronary Heart Disease. In: Galton, D.J., Assmann, G. (eds) DNA Polymorphisms as Disease Markers. NATO ASI Series, vol 214. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3690-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3690-1_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6640-9

  • Online ISBN: 978-1-4615-3690-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics